FM
fazen.markets
equities·esfritzh

Magnera Q4 Net Loss $141M on $106M Impairment, EBITDA Up 8%

0h ago|5 min readStandard
FM

Fazen Markets

Source: SEC EDGAR

Written by AI from a primary source ·

magneramagn-stockadjusted-ebitdagoodwill-impairmentfree-cash-flow

Key Takeaways

  • 1Magnera's cash engine and cost programs carried the year while a $106 million impairment and falling volumes dragged GAAP results into the red.

Partner

Trade 800+ Global Stocks & ETFs

Regulated Broker Competitive Spreads

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Magnera Corp (NYSE: MAGN) reported a fourth-quarter net loss of $141 million on 19 November 2026, driven by a $106 million goodwill and other impairment charge, while Adjusted EBITDA rose 8% year over year to $97 million. Net sales for the quarter ended 26 September 2026 reached $851 million against $839 million a year earlier, a 1% increase. Full-year net sales were $3.3 billion with a $37 million operating loss.

Context — why Magnera's impairment matters now

The headline loss and the operating figure tell different stories, and the gap is the entire story. The $106 million goodwill and other impairment is a non-cash charge the company booked in the September quarter, and it alone exceeds the $90 million quarterly operating loss. Strip it out and the quarter was profitable at the operating line. The company's own reconciliation shows the impairment split between segments: $65 million in Americas and $41 million in Rest of World.

That impairment lands on a balance sheet that has already shrunk. Total assets fell to $3.621 billion from $3.989 billion a year earlier, and goodwill, intangibles and other long-term assets dropped to $893 million from $1.090 billion. Stockholders' equity declined to $886 million from $1.064 billion. The write-down is the accounting recognition of that shrinkage, not a new cash outflow.

What triggered the charge is not disclosed in the report. The company did not break out which reporting unit or asset group drove the impairment, nor the valuation assumptions behind it. What the report does say is that the charge is excluded from the non-GAAP measures management uses to run the business.

CEO Curt Begle framed the year around cost control, citing "the successful implementation of Project CORE, ongoing realization of synergies, and a relentless focus on operational excellence." The company credits those programs with the price-cost spread that lifted EBITDA, and with the cash generation that funded debt paydown.

Data — what the numbers show

The split between GAAP and adjusted results is wide across every period in the release. Fourth-quarter operating income was a $90 million loss on a GAAP basis versus $10 million of income a year earlier. Full-year operating income was a $37 million loss versus $5 million of income in fiscal 2025. Adjusted EBITDA moved the other direction in both periods.

MetricQ4 2026Q4 2025FY 2026FY 2025
Net sales$851M$839M$3,296M$3,204M
Operating income (loss)$(90)M$10M$(37)M$5M
Adjusted EBITDA$97M$90M$378M$354M

On a comparable basis, which normalizes foreign currency and the recent M&A activity, fourth-quarter net sales rose 1% and Adjusted EBITDA rose 8%. For the full year, comparable Adjusted EBITDA rose 4% while reported Adjusted EBITDA rose 7%. The company's reconciliation shows the comparable full-year figure at $365 million against the reported $354 million, with a further adjustment to $397 million on a pro forma basis for divestitures, mergers, synergies and cost reductions.

Segment detail shows where the spread came from. Americas fourth-quarter Adjusted EBITDA was $65 million, up 7% on a comparable basis, on a $4 million favorable price-cost spread the company attributes to Project CORE and merger synergies. Rest of World Adjusted EBITDA was $32 million, up 10% comparable, on a $5 million favorable spread partly offset by lower volumes.

Volume was the weak spot. Consolidated organic volumes fell 4% in the quarter, with softer healthcare demand in the Americas and continued general market softness in Europe. Selling prices added $43 million, mostly pass-through of higher raw material costs.

Analysis — what it means for markets and sectors

Magnera sits in absorbent hygiene, protective apparel, wipes, specialty building products and food and beverage materials, a mix that ties it to healthcare consumption, construction activity and consumer staples volumes. The 4% organic decline with a 6% drop in Rest of World volumes signals that end-market demand, not pricing, is the constraint. Price pass-through is holding revenue roughly flat while volumes erode.

Cash is the counterweight. Full-year cash from operations was $178 million against $103 million a year earlier, and free cash flow of $115 million represents a yield above 25% on the company's year-end market capitalization. The company repaid $122 million of debt during the year, cutting current and long-term debt to $1.848 billion from $1.952 billion. Interest net expense was $150 million for the year versus $141 million, so paydown has not yet moved the interest line materially.

The limitation in the bull case is that EBITDA growth is coming from cost programs and price-cost spread rather than volume. Project CORE and merger synergies are finite; each dollar of realized savings is a one-time step, not a compounding growth engine. If volumes keep declining, the company eventually runs out of costs to cut.

The bear case has its own weakness. The $106 million impairment is non-cash and does not touch liquidity, and the company still generated positive free cash flow while funding debt reduction. Positioning reflects that tension: income-oriented holders get a high free cash flow yield, while the GAAP loss and equity decline of $178 million year over year keep valuation-focused buyers on the sidelines. The company did not disclose a dividend or buyback in the report.

Outlook — what to watch next

The company guided fiscal 2027 Adjusted EBITDA to $390-$410 million, a midpoint of $400 million and roughly 6% above fiscal 2026's $378 million. Free cash flow guidance is $110-$130 million, below the $115 million delivered in fiscal 2026 at the midpoint, with cash from operations of $195-$215 million and net additions to property, plant and equipment of $85 million.

The gap between rising EBITDA and roughly flat free cash flow is the item to track. Higher capital spending of $85 million versus $63 million in fiscal 2026 absorbs most of the operating cash improvement. Management also said it is "committed to strengthening its credit metrics by paying down debt in the near term," which points to continued repayment rather than shareholder returns.

The company will host a conference call on 19 November 2026 at 10:00 AM U.S. Eastern Time to discuss the results. The report did not disclose segment-level guidance or a fiscal 2027 impairment expectation.

Frequently Asked Questions

Why did Magnera report a net loss if Adjusted EBITDA rose?

The $141 million fourth-quarter net loss includes a $106 million non-cash goodwill and other impairment that GAAP requires but that the company excludes from Adjusted EBITDA. The loss also reflects $38 million of interest net expense and a $34 million income tax expense. Adjusted EBITDA of $97 million measures operating performance before those items, which is why the two figures diverge so widely.

What does Magnera's 25% free cash flow yield mean for shareholders?

Free cash flow of $115 million against a year-end market capitalization implies a yield above 25%, meaning the business generated cash equal to more than a quarter of its equity value. That cash funded $122 million of debt repayment. It does not automatically reach shareholders, since the company said it is prioritizing credit metrics through near-term debt paydown.

What is Project CORE and how much did it contribute?

Project CORE is the cost program Magnera credits, alongside merger synergies, for its favorable price-cost spread. The company attributed $4 million of Americas and $5 million of Rest of World fourth-quarter spread to those programs. The report does not quantify total Project CORE savings or state when the program ends.

Bottom Line

Magnera's cash engine and cost programs carried the year while a $106 million impairment and falling volumes dragged GAAP results into the red.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.

PartnerTrade 800+ global stocks & ETFs

Start Trading
Share

Stay informed

Get market analysis delivered to your inbox.

Join 18,500+ investors

Sponsored

Ready to trade the markets?

Open a demo account in 30 seconds. No deposit required.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Related